These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 25517810)

  • 1. Evaluating the role of primary care physicians in the treatment of latent tuberculosis: a population study.
    Rubinowicz A; Bartlett G; MacGibbon B; Greenaway C; Ronald L; Munoz M; Menzies D
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1449-54. PubMed ID: 25517810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of pediatric latent tuberculosis infection in a community health center clinic.
    Young J; Edick T; Klee D; O'Connor ME
    Pediatr Infect Dis J; 2012 Sep; 31(9):e147-51. PubMed ID: 22531235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of nurse-managed latent tuberculous infection treatment among hard-to-reach immigrants in Israel.
    Bishara H; Ore L; Vinitsky O; Bshara H; Armaly N; Weiler-Ravell D
    Int J Tuberc Lung Dis; 2015 Jul; 19(7):799-804. PubMed ID: 26056104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study.
    Schein YL; Madebo T; Andersen HE; Arnesen TM; Dyrhol-Riise AM; Tveiten H; White RA; Winje BA
    BMC Infect Dis; 2018 Nov; 18(1):587. PubMed ID: 30453946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latent tuberculosis treatment completion rates from prescription drug administrative data.
    Plourde PJ; Basham CA; Derksen S; Schultz J; McCulloch S; Larcombe L; Kinew KA; Lix LM
    Can J Public Health; 2019 Dec; 110(6):705-713. PubMed ID: 31297736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifampicin plus isoniazid for the prevention of tuberculosis in an immigrant population.
    Jiménez-Fuentes MA; de Souza-Galvao ML; Mila Augé C; Solsona Peiró J; Altet-Gómez MN
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):326-32. PubMed ID: 23407221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to treatment of latent tuberculosis infection in a clinical population in New York City.
    Li J; Munsiff SS; Tarantino T; Dorsinville M
    Int J Infect Dis; 2010 Apr; 14(4):e292-7. PubMed ID: 19656705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of latent tuberculous infection and treatment completion for refugees in Philadelphia, PA, 2010-2012.
    Subedi P; Drezner KA; Dogbey MC; Newbern EC; Yun K; Scott KC; Garland JM; Altshuler MJ; Johnson CC
    Int J Tuberc Lung Dis; 2015 May; 19(5):565-9. PubMed ID: 25868025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug, patient, and physician characteristics associated with off-label prescribing in primary care.
    Eguale T; Buckeridge DL; Winslade NE; Benedetti A; Hanley JA; Tamblyn R
    Arch Intern Med; 2012 May; 172(10):781-8. PubMed ID: 22507695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for failure to complete a course of latent tuberculosis infection treatment in Salvador, Brazil.
    Machado A; Finkmoore B; Emodi K; Takenami I; Barbosa T; Tavares M; Reis MG; Arruda S; Riley LW
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):719-25. PubMed ID: 19460247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Accessibility and compliance of Ethiopian immigrants to latent tuberculosis infection treatment].
    Bishara H; Ore L; Bshara H; Vinitsky O; Armaly N; Weiler-Ravell D
    Harefuah; 2014 Jan; 153(1):8-11, 66. PubMed ID: 24605398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with failure to complete isoniazid treatment for latent tuberculosis infection in Rhode Island.
    Kwara A; Herold JS; Machan JT; Carter EJ
    Chest; 2008 Apr; 133(4):862-8. PubMed ID: 18071014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of latent tuberculosis infection treatment completion in the US private sector: an analysis of administrative claims data.
    Stockbridge EL; Miller TL; Carlson EK; Ho C
    BMC Public Health; 2018 May; 18(1):662. PubMed ID: 29843664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated With Latent Tuberculosis Infection Treatment Failure Among Patients With Commercial Health Insurance-United States, 2005-2016.
    Iqbal SA; Isenhour CJ; Mazurek G; Langer AJ; Chang MH; Truman BI
    J Public Health Manag Pract; 2021 Jul-Aug 01; 27(4):E151-E161. PubMed ID: 31688742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active case finding and prevention of tuberculosis among a cohort of contacts exposed to infectious tuberculosis cases in New York City.
    Anger HA; Proops D; Harris TG; Li J; Kreiswirth BN; Shashkina E; Ahuja SD
    Clin Infect Dis; 2012 May; 54(9):1287-95. PubMed ID: 22412056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of contact tracing completion and outcomes in tuberculosis: a 21-year retrospective cohort study.
    Saunders MJ; Koh GC; Small AD; Dedicoat M
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):640-6. PubMed ID: 24903932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment.
    Trajman A; Long R; Zylberberg D; Dion MJ; Al-Otaibi B; Menzies D
    Int J Tuberc Lung Dis; 2010 May; 14(5):551-9. PubMed ID: 20392347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for treatment default in close contacts with latent tuberculous infection.
    Fiske CT; Yan FX; Hirsch-Moverman Y; Sterling TR; Reichler MR;
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):421-7. PubMed ID: 24670696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care.
    Tamblyn R; Huang A; Perreault R; Jacques A; Roy D; Hanley J; McLeod P; Laprise R
    CMAJ; 2003 Sep; 169(6):549-56. PubMed ID: 12975221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Better Completion of Pediatric Latent Tuberculosis Treatment Using 4 Months of Rifampin in a US-based Tuberculosis Clinic.
    Gaensbauer J; Aiona K; Haas M; Reves R; Young J; Belknap R
    Pediatr Infect Dis J; 2018 Mar; 37(3):224-228. PubMed ID: 28777204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.